Activa Healthcare has changed its name to L&R
Debrisoft is a rapid, highly effective, safe and easy method of debridement for acute and chronic wounds. Debrisoft is ideal for superficial wounds and is also very effective in the removal of hyperkeratosis from the skin. While NEW Debrisoft Lolly has been specially developed to debride deep, surgically-invasive and hard-to-reach area of wounds and skin.
Open the Debrisoft single-use, sterile pack
Fully moisten the soft, fleecy side of the Debrisoft pad with 20-40ml (1-2 egg cups) of tap water or saline. (Always refer to local guidelines.)
Gently, with light pressure, as if exfoliating, use the soft, fleecy side of the moistened Debrisoft in a circular motion (on wounds) or in long, sweeping strokes (on the skin).
Use a new piece of Debrisoft for each separate wound/area of skin and dispose of the used Debrisoft in normal clinical or household waste.
Open the Debrisoft Lolly single-use, sterile pack.
Fully moisten the head of the Debrisoft Lolly while in the packet with 5-15ml tap water or saline*, which is equivalent to 1-3 teaspoons. (*Always refer to local guidelines).
Clean the wound and/or hard-to-reach areas by applying gentle pressure with the soft, fibre head of the moistened Debrisoft Lolly.
Use a new Debrisoft Lolly for each separate area. If necessary, clean the skin surrounding the wound with a moistened Debrisoft pad. Dispose of the used Debrisoft Lolly (and pad) in normal clinical or household waste.
Debriding with Debrisoft, from Activa Healthcare, can result in a marked visible difference within a matter of days. This reduces the number and frequency of nurse visits and significant savings can be passed on to the NHS.
According to 2014 NICE guidance, using Debrisoft could result in savings of up to £15 million per annum nationally/up to £484 per patient.
The cost of preventing and treating pressure ulcers in a 600 bed acute trust has been estimated at between £600,000 and £3m a year (Touche R; 1993). The total cost in the UK is estimated to be £1.4 - £2.1 billion annually, comprising 4% of total NHS expenditure1.
Correct classification of Pressure Ulcers is vital to ensure that the patient gets the correct care regime, but also that the correct information is compiled, and to avoid unnecessary use of time and resources such as pressure relieving equipment.
A recent paper (Swann J, Orig R, 2013) revealed using Debrisoft can assist in the correct classification of Pressure Ulcers and help reduce nurse time and incorrect reporting by identifying the appropriate care regime, thereby reducing costs for the NHS.
1 Bennett G, Dealey C, Posnett J, (2004). The cost of pressure ulcers in the UK. Age and Ageing 2004; 33: 230-235.
Advice and information from leading Tissue Viability Nurses (TVNs) and specialists.